,20,21 In a small study, incorporating DAC into lymphodepletion significantly improved response durability, resulting in longer PFS and OS in patients with B-ALL receiving CD19/CD22 CAR T cells.22 The gene discussed is CD22; the disease is precursor B-cell acute lymphoblastic leukemia.